GIST, Malignant: Clinical Trials

7 trials for GIST, Malignant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 2 terminated. 3 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Terminated 2, Unknown 1
Phase 21Unknown 1

Follow GIST, Malignant: new trials by email Literature Review of GIST, Malignant trials Research Report on GIST, Malignant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liver Transplantation for Unresectable GIST Liver Metastases
Liver Transplantation - Liver Diseases, Liver Cancer
Not applicableUnknownHospital Universitario Virgen de la Arrixaca502022-05-012022-03-11
French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients
Patient treated by Avapritinib in real life - GIST, GIST, Malignant
UnknownCentre Leon Berard252021-03-312023-12-26
GIST and Memory and Attention Adaptation Training
MAAT - GIST, Malignant, CBT
Not applicableTerminatedUniversity of Pittsburgh22021-01-122024-07-16
Nutrition in Gastrointestinal Tumors
No intervention - observational study only - Pancreatic Cancer, Oesophageal Cancer
CompletedUniversity Medicine Greifswald662020-06-252023-01-25
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
Serious Illness Conversation Guide (SICG), Quality of Life (QOL) survey - Gastrointestinal Cancer, Colorectal Cancer
Not applicableTerminatedStanford University122019-09-162023-01-27
POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST
Ponatinib 30 MG - GIST, Malignant, KIT Exon 13 Mutation
Phase 2UnknownSebastian Bauer812017-03-222017-05-31
Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM
imatinib (IM), hepatic resection (HR), radiofrequency ablation (RFA) - GIST, Malignant, Liver Metastases
CompletedFirst Affiliated Hospital, Sun Yat-Sen University2382002-01-012025-02-26

Narrower conditions

Gastrointestinal Stromal Tumors (7)  ·  Carcinoma, Hepatocellular (2)  ·  Esophageal Neoplasms (2)  ·  Liver Neoplasms (2)  ·  Neuroendocrine Tumors (2)  ·  Stomach Neoplasms (2)  ·  Bile Duct Neoplasms (1)  ·  Cholangiocarcinoma (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Liver Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)  ·  Rectal Neoplasms (1)

Broader conditions

Digestive System Diseases (7)  ·  Digestive System Neoplasms (7)  ·  Gastrointestinal Diseases (7)  ·  Neoplasms (7)  ·  Neoplasms by Histologic Type (7)  ·  Neoplasms, Connective Tissue (7)  ·  Neoplasms, Connective and Soft Tissue (7)  ·  Gastrointestinal Neoplasms (6)  ·  Neoplasms by Site (3)  ·  Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Colonic Diseases (2)  ·  Esophageal Diseases (2)  ·  Head and Neck Neoplasms (2)  ·  Intestinal Diseases (2)

Interventions

Imatinib Mesylate (1)  ·  Liver Transplantation (1)  ·  Quality of Life (1)  ·  Radiofrequency Ablation (1)  ·  Surveys and Questionnaires (1)  ·  ponatinib (1)

Sponsors

Centre Leon Berard (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)  ·  Hospital Universitario Virgen de la Arrixaca (1)  ·  Sebastian Bauer (1)  ·  Stanford University (1)  ·  University Medicine Greifswald (1)  ·  University of Pittsburgh (1)

Countries

Germany (2)  ·  United States (2)  ·  China (1)  ·  France (1)  ·  Spain (1)

Top investigators

Ali A Aghdassi, Professor (1)  ·  Anette U Duensing, MD (1)  ·  Robert J Ferguson, PhD (1)  ·  Sebastian Bauer, Prof. Dr. (1)  ·  Tyler P Johnson, MD (1)

Results publications

PMID 35091442